What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Asthma
Alberto Papi mainly focuses on COPD, Immunology, Asthma, Respiratory disease and Internal medicine.
His COPD study integrates concerns from other disciplines, such as Oxidative stress, Intensive care, Pathology, Sputum and Lung.
His work on Immunology deals in particular with Rhinovirus, Exacerbation, Inflammation, Cytokine and Chemokine.
His Asthma research incorporates elements of Eosinophilia, Placebo and Anesthesia.
His studies deal with areas such as Respiratory tract, Pathophysiology and Vital capacity as well as Respiratory disease.
While the research belongs to areas of Internal medicine, Alberto Papi spends his time largely on the problem of Gastroenterology, intersecting his research to questions surrounding Bronchodilator.
His most cited work include:
- First result from the Alpha Magnetic Spectrometer on the International Space Station: precision measurement of the positron fraction in primary cosmic rays of 0.5-350 GeV. (864 citations)
- Role of deficient type III interferon-λ production in asthma exacerbations (813 citations)
- Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. (765 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, COPD, Asthma, Immunology and Exacerbation.
In general Internal medicine, his work in Corticosteroid, Fluticasone propionate and Dupilumab is often linked to In patient linking many areas of study.
In his study, which falls under the umbrella issue of COPD, MEDLINE is strongly linked to Pulmonary disease.
His study in Asthma is interdisciplinary in nature, drawing from both Anesthesia, Pediatrics and Intensive care medicine.
His Exacerbation research is multidisciplinary, relying on both Beclometasone dipropionate and Metered-dose inhaler.
His studies in Rhinovirus integrate themes in fields like Respiratory epithelium and ICAM-1.
He most often published in these fields:
- Internal medicine (39.32%)
- COPD (37.43%)
- Asthma (35.16%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (39.32%)
- Asthma (35.16%)
- COPD (37.43%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Asthma, COPD, Exacerbation and Intensive care medicine.
His study in the fields of Dupilumab, Adverse effect and Corticosteroid under the domain of Internal medicine overlaps with other disciplines such as In patient.
His Asthma research includes elements of Moderate to severe and Lama.
His COPD research includes themes of Pulmonary disease, Clinical trial, Metered-dose inhaler and Immunology.
His work is dedicated to discovering how Exacerbation, Inhaler are connected with Fluticasone propionate and other disciplines.
Alberto Papi works mostly in the field of Intensive care medicine, limiting it down to topics relating to Disease and, in certain cases, Comorbidity, as a part of the same area of interest.
Between 2018 and 2021, his most popular works were:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (472 citations)
- Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma (123 citations)
- Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS) : baseline data from a prospective cohort study (71 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Internal medicine, COPD, Asthma, Intensive care medicine and Exacerbation.
Alberto Papi combines subjects such as Omalizumab and Placebo with his study of Internal medicine.
His COPD study combines topics from a wide range of disciplines, such as Pulmonary disease, Respiratory infection, Clinical trial and Pneumonia.
His research integrates issues of Gastroenterology, Lower risk, Inhalation and Randomized controlled trial in his study of Asthma.
His work carried out in the field of Intensive care medicine brings together such families of science as Disease, Asthma control and MEDLINE.
The study incorporates disciplines such as Exhaled nitric oxide, Triple combination, Indacaterol and Risk factor in addition to Exacerbation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
